mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |